eMed Review
GLP-1 weight-loss telehealth · Independently scored 4.4/10
eMed falls below our bar on disclosure. Read the breakdown below before you give it money.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the plan
Medication
Not stated
Clinician visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Prices checked June 2026
Employers are eMed's real channel, and CVS Caremark, a pharmacy benefit manager, sits in the middle; how much of the drug cost gets subsidized is the employer's call. For most people that rules out any transparent cash price. The company made its name in at-home diagnostics and has since built a GLP-1 weight management program with clinician support behind it. Members fill in a medical profile and collect blood at home, a licensed clinician judges eligibility, and branded semaglutide or tirzepatide may follow, with help on side effects and adherence afterward.
Is eMed legit?
Yes. eMed is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 4.4/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there an eMed promo or coupon code?
We know of no promo or coupon code for eMed. Coupon sites advertising "eMed discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how eMed compares on our rankings of the best weight-loss injection providers.
Vetted alternatives to eMed
Trimi Health
Best for: knowing which pharmacy fills the vial: it names VialsRx
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
eMed at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- FDA status
- No FDA warning letters found
How eMed scores
Six columns, each one computed from something eMed has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
3.0/10There is no monthly price to compare, so Value is capped rather than scored against other sellers.
Effectiveness25%
5.0/10No medication list or price is available to score, so this is held at the midpoint. It is not a judgment on the drugs themselves.
User Experience15%
5.0/10Where this seller first shows a price is not known, so sign-up is held at the midpoint.
Trust & Safety15%
4.0/10No pharmacy is named for its prescriptions. There is no confirmed price before the medical intake.
Accessibility10%
5.0/10No state list is available to check, so this is held at the midpoint rather than scored on reach.
Support10%
5.0/10No published price, so what a price would include cannot be assessed. Held at the midpoint.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on eMed
Last checked June 2026- Checked FDA warning letters for eMed
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
GLP-1 medications eMed offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
In its favor
- We found no FDA warning letters issued to eMed
Against it
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
What eMed charges
There is no standard monthly price to quote for eMed, so you cannot compare it with other sellers until you have been through an intake and received a quote. When you get one, ask for the ongoing monthly figure and what it includes, not the first-month rate and not a program total divided by its length.
What eMed dispenses
eMed prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market.
Safety and disclosure
Before you start an intake, ask eMed which states it serves, which pharmacy fills its prescriptions and what the monthly price includes. We found no FDA warning letters issued to eMed. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You want to compare prices before spending time on an intake. There is no standard monthly price to compare.
- You need insurance to cover the cost. Check whether eMed bills your plan before you start.
Our read
Whether eMed is priced well is impossible to judge before an intake, because there is no standard price to compare. That does not rule it out, and plenty of legitimate sellers quote after intake, but it puts the comparison after you have spent the time, which is the wrong order for you as the buyer. Collective is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
eMed falls below our bar on disclosure. Read the breakdown below before you give it money.
Before you pay eMed
Check today's price, then start the intake.
Where eMed is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these two counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider Sesame Care.
- If you want a human checking in, not just a prescription, consider ShedRx.
Compare eMed head to head
The sellers closest to eMed on medication and price.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this eMed review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of June 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
See eMed's current pricing
Whether you qualify is a clinician's decision, made after your intake.